股市必读：开立医疗三季报 - 第三季度单季净利润同比增长78.05%

Key Points - The core viewpoint of the articles highlights the financial performance and shareholder dynamics of Kaili Medical as of October 28, 2025, indicating a mixed financial outlook with a significant drop in net profit despite revenue growth [1][2]. Trading Information Summary - On October 28, 2025, Kaili Medical's stock closed at 34.15 yuan, up 0.29%, with a turnover rate of 0.84%, a trading volume of 36,300 shares, and a transaction value of 124 million yuan [1]. - The net outflow of funds from major investors was 13.95 million yuan, while retail investors saw a net inflow of 15.39 million yuan [1][4]. Shareholder Changes Summary - As of September 30, 2025, the number of shareholders increased to 16,100, up by 1,824, representing a growth of 12.75% since June 30, 2025 [1][4]. - The average number of shares held per shareholder decreased from 30,200 to 26,800, with an average market value of 922,200 yuan per shareholder [1]. Financial Performance Summary - For the third quarter of 2025, Kaili Medical reported a main revenue of 1.459 billion yuan, a year-on-year increase of 4.37%, while the net profit attributable to shareholders was 33.51 million yuan, down 69.25% year-on-year [2]. - The third quarter alone saw a main revenue of 495 million yuan, up 28.42% year-on-year, but the net profit was -13.52 million yuan, an increase of 78.05% year-on-year in losses [2]. - The company reported a debt ratio of 24.22%, investment income of 2.08 million yuan, financial expenses of -38.30 million yuan, and a gross profit margin of 60.36% [2]. Company Announcement Summary - On October 27, 2025, Kaili Medical's supervisory board held its 11th meeting, approving the third quarter report, confirming that the report's preparation and review processes complied with legal and regulatory requirements, and that the content was true, accurate, and complete [2][4].